** Shares of Mesoblast rise as much as 4.4% to A$1.1750, their highest levels since July 25
** The biotechnology firm enters into a convertible note subscription agreement to raise $50 mln with its largest shareholder Gregory George
** Says issue price of A$1.32 per share is at a ~17% premium, as of co's last trading price on Sept 27
** MSB stock up 270.9% YTD, including current session's moves
(Reporting by Kumar Tanishk in Bengaluru)
((Tanishk.Kumar@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。